Acute myeloblastic leukemia after cure of ovarian cancer.
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000473:pathology; D000284:Administration, Oral; D000328:Adult; D002277:Carcinoma / Q000188:drug therapy* / Q000473:pathology; D004715:Endometriosis / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced*; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000473:pathology; D013852:Thiotepa / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D013997:Time Factors
D013852:Thiotepa; D008727:Methotrexate